Phenyl tetrahydroisoquinoline compound substituted with heteroaryl
US9932331B2 · kind B2 · utility
0Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 2015 |
| Grant date | Apr 3, 2018 |
| Priority date | — |
| Expiry date | Jul 24, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound represented by the following formula [1] or a pharmaceutically acceptable salt thereof which has an excellent NHE3 inhibitory effect:A-Y [1]wherein
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.